The tuberculosis-associated immune reconstitution inflammatory syndrome

@inproceedings{Stek2019TheTI,
  title={The tuberculosis-associated immune reconstitution inflammatory syndrome},
  author={Cari Stek and Sean Wasserman},
  year={2019}
}
Walker, NF; Stek, C; Wasserman, S; Wilkinson, RJ; Meintjes, G; (2018) The tuberculosisassociated immune reconstitution inflammatory syndrome: recent advances in clinical and pathogenesis research. Current opinion in HIV and AIDS. ISSN 1746-630X DOI: https://doi.org/10.1097/COH.0000000000000502 Downloaded from: http://researchonline.lshtm.ac.uk/4648967/ DOI: https://doi.org/10.1097/COH.0000000000000502 

Figures and Tables from this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 56 REFERENCES

Impact Of Raltegravir Intensification Of First-line ART On IRIS In The Reality Trial. Conference on Retroviruses and Opportunistic Infections

DM Gibb, AJ Szubert, E Chidziva
  • 2018

Urgent versus post-stabilisation antiretroviral treatment in hospitalised HIV-infected children in Kenya (PUSH): a randomised controlled trial

IN Njuguna, LM Cranmer, VC Otieno
  • Lancet HIV 2018; 5(1):e12–e22
  • 2018

Randomised Controlled Trial Of Prednisone For Prevention Of Paradoxical TB-IRIS. Conference on Retroviruses and Opportunistic Infections

G Meintjes, C Stek, L Blumenthal
  • 2017